- Medtronic plc
- Abbott Laboratories
- F.Hoffmann-La-Ltd.
- Bayer AG
- Lifescan, Inc.
- B Braun Melsungen AG
- Lifescan, Inc.
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc.
- Novo Nordisk
- Arkray, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Diabetes Device Market:
In April 2022- A partnership between Abbott, CamDiab, and Ypsomed was announced in order to create and market an integrated automated insulin delivery (AID) system in European nations. The linked smart wearable device is intended to continuously track a person's blood sugar levels and automatically modify and give the appropriate dose of insulin at the appropriate time, doing away with the need for guessing in insulin dosing.
The most common type of disease, type 2 diabetes, affects more than 31 million Americans, according to the U.S. Centres for Disease Control and Prevention. Being overweight or obese, being over 45, having a close relative with the disease, exercising less than three times per week, and having a history of gestational diabetes (diabetes during pregnancy) are all risk factors for Type 2 diabetes. A heart attack is twice as likely to occur among individuals with Type 2 diabetes as in those without the condition, and it also raises the risk of generating heart disease and stroke. Therefore, it is anticipated that risk factors like smoking, being overweight, obesity, and high cholesterol levels will increase the prevalence of diabetes and increase the demand for diabetes devices. Moreover, the availability of expensive insulin pens and pumps, as well as other technological advancements in diabetic equipment, are increasing the demand for these products. Top manufacturers are focusing on technological developments and the creation of cutting-edge items in order to take a sizable share of the market. A growing number of individuals use blood glucose meters because of their advantages, mobility, and precision. Market players are focusing on the development of these devices and introducing miniature blood glucose meters. Additionally, several government initiatives and public awareness campaigns support market expansion. However, diabetes gadgets don't always provide accurate results. Multiple issues are also preventing the market from expanding. Inconvenient sensor insertions and the challenge of placing multiple devices on small bodies are a couple of such instances. Disruptive alarms also resulted in signal loss, which led to data gaps, skin rashes, adhesion issues, and a proliferation of cumbersome, challenging-to-understand data generated by diabetes care devices.